Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase NA 2Phase 2 2Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 19Leukemia 16Myelodysplastic Syndromes 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neuroblastoma 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Multiple Myeloma 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myelomonocytic, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Congenital Abnormalities 3Sarcoma, Ewing 2Neoplasms, Plasma Cell 2Myeloproliferative Disorders 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Graft vs Host Disease 2Burkitt Lymphoma 2Anemia, Refractory, with Excess of Blasts 2Sarcoma 1Recurrence 1

Interventions

Vincristine 5Ifosfamide 5Etoposide 5Radiotherapy 4Doxorubicin 4Cyclophosphamide 4Dactinomycin 3Neoadjuvant Therapy 2Chemotherapy, Adjuvant 2Brachytherapy 2etoposide phosphate 1Topotecan 1Temozolomide 1Mesna 1Melphalan 1Irinotecan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Fentanyl 1FANG vaccine 1Epirubicin 1Dexrazoxane 1Cyproheptadine 1Carboplatin 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neuroectodermal Tumors, Primitive, Peripheral × Busulfan × Clear all
NCT00020566 2014-06-24

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
1,200 enrolled
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡